Related references
Note: Only part of the references are listed.Contra-Directional Expression of Plasma Superoxide Dismutase with Lipoprotein Cholesterol and High-Sensitivity C-reactive Protein as Important Markers of Parkinson's Disease Severity
Wanlin Yang et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers
Nour K. Majbour et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson's Disease
Fen Xie et al.
ACS CHEMICAL NEUROSCIENCE (2019)
α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
Inger van Steenoven et al.
MOVEMENT DISORDERS (2018)
Melatonin alleviates cadmium-induced liver injury by inhibiting the TXNIP-NLRP3 inflammasome
Zhengwang Cao et al.
JOURNAL OF PINEAL RESEARCH (2017)
The role of CIP2A in cancer: A review and update
Saiedeh Razi Soofiyani et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
Xuewen Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Alpha-Synuclein as a Biomarker for Parkinson's Disease
Anzari Atik et al.
BRAIN PATHOLOGY (2016)
The novel mechanism of rotenone-induced α-synuclein phosphorylation via reduced protein phosphatase 2A activity
Yi Wang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease
Nour K. Majbour et al.
MOLECULAR NEURODEGENERATION (2016)
Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies
Hye-Jin Park et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Increased oligomerization and phosphorylation of α-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains
Guangwei Liu et al.
NEUROBIOLOGY OF AGING (2015)
Protein Phosphatase 2A is Involved in the Tyrosine Hydroxylase Phosphorylation Regulated by α-Synuclein
Gao Hua et al.
NEUROCHEMICAL RESEARCH (2015)
Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents
Shuke Nie et al.
NEUROPHARMACOLOGY (2015)
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
Senthilkumar S. Karuppagounder et al.
SCIENTIFIC REPORTS (2014)
CIP2A increases self-renewal and is linked to Myc in neural progenitor cells
Laura Kerosuo et al.
DIFFERENTIATION (2010)
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
Min Shi et al.
NEUROSCIENCE LETTERS (2010)
CIP2A inhibits PP2A in human malignancies
Melissa R. Junttila et al.
CELL (2007)
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson-Lewis et al.
NATURE PROTOCOLS (2007)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
Behavioral phenotyping of mice in pharmacological and toxicological research
T Karl et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2003)
Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer
LS Hoo et al.
ONCOGENE (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Share Paper
